LncRNA HOST2通过与ELAVL1的相互作用促进NSUN2介导的乳腺癌进展
Xuehui Wang1, Diya Liu1, Kaiyao Hua1
1Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China; Institute of Breast Disease, School of Medicine, Tongji University, Shanghai 200072, China.
Cellular signalling
|February 22, 2024
概括
这项研究表明,HOST2 阻断了 ELAVL1 降解,稳定了 NSUN2 mRNA,促进了乳腺癌 (BC) 的进展. 准HOST2/ELAVL1/NSUN2通路为BC提供了一个潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 在RNA生物学,RNA生物学.
背景情况:
- 乳腺癌 (BC) 是全球女性癌症相关死亡的主要原因.
- 一种RNA甲基转移酶NSUN2与瘤细胞增殖和转移有关.
- 提高NSUN2表达与乳腺癌患者的预后不佳相关.
研究的目的:
- 阐明NSUN2在乳腺癌进展中的调控机制.
- 为了确定参与NSUN2mRNA稳定性的关键分子.
- 探索HOST2/ELAVL1/NSUN2轴作为乳腺癌治疗点的潜力.
主要方法:
- 对乳腺癌组织和细胞系中NSUN2表达的分析.
- 在体外和体内实验涉及NSUN2敲击乳腺癌细胞的实验.
- 研究RNA结合蛋白ELAVL1与NSUN2 mRNA的相互作用.
- 确定长非编码RNA HOST2 在 ELAVL1 蛋白质稳定性中的作用.
主要成果:
- 在乳腺癌中,NSUN2被上调,并与患者的不良结果有关.
- NSUN2淘汰抑制乳腺癌细胞的增殖和迁移.
- ELAVL1与NSUN2mRNA结合,提高了它的稳定性.
- HOST2 阻止了 ELAVL1 的蛋白质体降解,从而稳定了 NSUN2 mRNA.
结论:
- 这项研究发现了一种新的HOST2/ELAVL1/NSUN2信号通路,对乳腺癌进展至关重要.
- HOST2通过抑制ELAVL1降解来稳定NSUN2mRNA.
- 这一途径代表了乳腺癌治疗的有前途的新型治疗标.
更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K


